Skip to content

Dr. K. Dubejko: what changed

BE 0803.812.571NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€28,465
2024 · €46,561-€18,096
Equity
€96,171
2024 · €67,706+€28,465
Cash
€90,112
2024 · €68,132+€21,980
Balance sheet total
€98,409
2024 · €72,917+€25,492

Largest movements

2024 to 2025
Assets
  • Cash +€21,980

    up €21,980 (+32.3%), from €68,132 to €90,112

    mainly Net result for the year (+€28,465) and Depreciation (+€1,599)

  • Receivables within one year +€4,776

    new in 2025: €4,776

  • Tangible fixed assets -€1,599

    down €1,599 (-36.8%), from €4,348 to €2,749

    of which Furniture and vehicles: -€1,416

Equity and liabilities
  • Profit (loss) carried forward +€28,465

    up €28,465 (+45.4%), from €62,706 to €91,171

  • Tax, wage and social debts -€2,683

    down €2,683 (-71.4%), from €3,755 to €1,072

Income statement
  • Gross operating margin -€21,301

    down €21,301 (-35.5%), from €59,969 to €38,668

  • Taxes -€4,459

    down €4,459 (-35.2%), from €12,683 to €8,224

  • Depreciation +€1,150

    up €1,150 (+256%), from €449 to €1,599

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €46,561
Gross operating margin -€21,301
Depreciation -€1,150
Other operating charges -€99
Financial charges -€5
Taxes +€4,459
Result 2025 €28,465
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€21,980
Investment €0
Financing €0
Cash 2024 €68,132
Net result for the year +€28,465
Depreciation +€1,599
Receivables within one year -€4,776
Deferred charges and accrued income -€335
Tax, wage and social debts -€2,683
Other debts -€458
Accrued charges and deferred income +€168
Cash 2025 €90,112
brings cash intakes cash out
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €72,917 €98,409 +€25,492 +35.0%
Fixed assets 21/28 €4,348 €2,749 -€1,599 -36.8%
Tangible fixed assets 22/27 €4,348 €2,749 -€1,599 -36.8%
Plant, machinery and equipment 23 €406 €223 -€183 -45.1%
Furniture and vehicles 24 €3,943 €2,527 -€1,416 -35.9%
Current assets 29/58 €68,569 €95,660 +€27,091 +39.5%
Amounts receivable within one year 40/41 - €4,776 +€4,776
Other amounts receivable 41 - €4,776 +€4,776
Cash at bank and in hand 54/58 €68,132 €90,112 +€21,980 +32.3%
Deferred charges and accrued income 490/1 €437 €772 +€335 +76.7%
Total equity and liabilities 10/49 €72,917 €98,409 +€25,492 +35.0%
Equity 10/15 €67,706 €96,171 +€28,465 +42.0%
Contributions 10/11 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 €62,706 €91,171 +€28,465 +45.4%
Amounts payable 17/49 €5,210 €2,238 -€2,973 -57.1%
Amounts payable within one year 42/48 €4,882 €1,742 -€3,141 -64.3%
Taxes, remuneration and social security 45 €3,755 €1,072 -€2,683 -71.4%
Taxes 450/3 €3,755 €1,072 -€2,683 -71.4%
Other amounts payable 47/48 €1,128 €669 -€458 -40.6%
Accrued charges and deferred income 492/3 €328 €496 +€168 +51.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €449 €1,599 +€1,150 +256%
Other operating charges 640/8 €232 €331 +€99 +42.6%
Gross operating margin 9900 €59,969 €38,668 -€21,301 -35.5%
Operating profit (loss) 9901 €59,288 €36,738 -€22,550 -38.0%
Financial charges 65/66B €44 €49 +€5 +12.2%
Recurring financial charges 65 €44 €49 +€5 +12.2%
Profit (loss) for the period before taxes 9903 €59,244 €36,689 -€22,555 -38.1%
Income taxes 67/77 €12,683 €8,224 -€4,459 -35.2%
Profit (loss) for the period 9904 €46,561 €28,465 -€18,096 -38.9%
Profit (loss) for the period to be appropriated 9905 €46,561 €28,465 -€18,096 -38.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€156,621 to €200,036

Midpoint €174,711 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €96,171
Capitalised earnings €217,071 to €303,900
Indication €156,621 to €200,036

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€96,171
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€96,171

Capitalised earnings

net result for the year (9904)
2025
€28,465
2024
€46,561
2023
€16,146
Average result
€30,390
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€217,071 / €253,250 / €303,900

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 12 November 2026 via checked.be.